Haleon (HLN) Consolidated Net Income (2021 - 2025)
Haleon's (HLN) quarterly Consolidated Net Income came in at $1.1 billion in Q4 2025, down 51.46% on a QoQ basis from $2.2 billion in Q4 2023.
Haleon (HLN) Consolidated Net Income (2021 - 2025) Analysis & Trends
Haleon (HLN) has 4 years of Consolidated Net Income data on file, last reported at $1.1 billion in Q4 2025.
- Quarterly Consolidated Net Income changed N/A year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (changed N/A YoY) and the FY2025 annual result came in at $2.2 billion, up 18.52% from the prior year.
- Consolidated Net Income slipped to $1.1 billion in Q4 2025, from $2.2 billion in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $2.2 billion in Q4 2023 to a low of $652.0 million in Q2 2023.
- A 4-year average of $1.5 billion and a median of $1.5 billion in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income declined 0.63% — and 2023, when it climbed 5.76%.
- Tracing HLN's Consolidated Net Income over 4 years: stood at $2.1 billion in 2021, then dropped by 0.63% to $2.1 billion in 2022, then gained by 5.76% to $2.2 billion in 2023, then plunged by 51.46% to $1.1 billion in 2025.
- The last three Consolidated Net Income figures came in at $1.1 billion (Q4 2025), $2.2 billion (Q4 2023), and $652.0 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.09 Bn |
| Dec 31, 2023 | 2.24 Bn |
| Jun 30, 2023 | 651.96 Mn |
| May 3, 2023 | 818.04 Mn |
| Dec 31, 2022 | 2.12 Bn |
| Sep 20, 2022 | 1.46 Bn |
| Dec 31, 2021 | 2.14 Bn |